Nephrolithiasis: Why Doesn't Our "learning" Progress?

European Urology

Volumn 45, Issue 5, 2004, Pages 547-556

  Gambaro, Giovanni ^a   Reis Santos, Josè M ^b   Rao, Nagaraja ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b CATHOLIC UNIVERSITY OF PORTUGAL   (Portugal)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ESWL; Natural history; Nephrolithiasis; Relapse; Single stone former

Indexed keywords

DIURETIC AGENT;

CIGARETTE SMOKING; COST BENEFIT ANALYSIS; EPIDEMIOLOGICAL DATA; EXTRACORPOREAL LITHOTRIPSY; HEALTH CARE COST; HUMAN; NEPHROLITHIASIS; NUTRITION; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT SELECTION; POLLUTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SOCIOECONOMICS;

BIOMEDICAL RESEARCH; HUMANS; KIDNEY CALCULI;

EID: 1842788128     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2003.10.017     Document Type: Review

References (49)

1. Preminger G.M. Renal calculi: pathogenesis, diagnosis, and medical therapy. Semin. Nephrol. 12:1992;200-216.
2. Smith L.H. The medical aspects of urolithiasis: an overview. J. Urol. 141:1989;707-710.
3. Statistiche della Sanità. Roma: ISTAT; 1992-1995.
4. Pak C.Y.C. Medical prevention of renal stone disease. Nephron. 81(Suppl. 1):1999;60-65.
5. Robertson WG. The economics of urinary stone management. In: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A, editors. Proc. 8th Eur Symp on Urolith, Parma, Italy, June 1999. Cosenza: Editoriale Bios; 1999. p. 169-72.
6. Strohmaier WL. Economic aspects of nephrolithiasis: a critical review and future outlook. In: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A, editors. Proc. 8th Eur Symp on Urolith, Parma, Italy, June 1999. Cosenza: Editoriale Bios; 1999. p. 111-8.
7. Uribarri J., Oh M.S., Carroll H.J. The first kidney stone. Arch. Int. Med. 111:1989;1006-1009.
8. Williams R.E. Long-term survey of 538 patients with upper urinary tract stones. Br. J. Urol. 35:1963;416-437.
9. Blacklock NJ. The patterns of urolithiasis in the Royal Navy. In: Hodgkinson A, Nordin BE, editors. Renal Stone Research Symposium. London: Churchill; 1969. p. 33-47.
10. Marshall N., White R.H., De Saintonge M.C., Tresidder G.C., Blandy J.P. The natural history of renal and ureteric calculi. Br. J. Urol. 47:1975;117-124.
11. Ljunghall S., Christensson T., Wengle B. Prevalence and incidence of renal stone disease in a health screening program. Scand. J. Urol. Nephrol. 41(Suppl.):1977;29-53.
12. Johnson C.M., Wilson D.M., O'Fallon W.M., Malek R.S., Kurland L.T. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 16:1979;624-631.
13. Sutherland J.W., Parks J.H., Coe F.L. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 11:1985;267-269.
14. Ahlstrand C., Tiselius H.-G. Recurrence during a 10-year follow-up after first renal stone episode. Urol. Res. 18:1990;397-399.
15. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996;155:834-9.
16. Trinchieri A., Ostini F., Nespoli R., Rovera F., Montanari E., Zanetti G. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J. Urol. 162:1999;27-30.
17. Vahlensieck W., Hesse A., Bach D. Zur Prävalenz des Harnsteinleidens in der Bundesrepublik Deutschland. Urologe B. 20:1980;273-276.
18. Schneider HJ. Epidemiology of urolithiasis. In: Schneider HJ, editor. Urolithiasis: etiology, diagnosis. Berlin: Springer; 1985. p. 137-84.
19. Strohmaier W.L. Course of calcium stone disease without treatment. What can we expect? Eur. Urol. 37:2000;339-344.
20. Yoshida O., Terai A., Ohkawa T., Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int. 56:1999;1899-1904.
21. Coe F.L., Keck J., Norton E.R. The natural history of calcium urolithiasis. JAMA. 238:1977;1519-1523.
22. Gambaro G., Petrarulo M., Nardelotto A., Marangella M., Baggio B. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis. Kidney Int. 48:1995;1549-1552.
23. Etinger B., Pak C.Y.C., Citron J.T., Thomas C., Adams-Huet B., Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J. Urol. 158:1997;2069-2073.
24. Di Silverio F., Ricciuti G.P., D'Angelo A.R., Fraioli A., Simeoni G. Stone recurrence after lithotripsy in patients with recurrent idiopathic calcium urolithiasis: efficacy of treatment with Fiuggi water. Eur. Urol. 37:2000;145-148.
25. Pak C.Y.C. Should patients with single renal stone occurrence undergo diagnostic evaluation? J. Urol. 127:1982;855-858.
26. Yagisawa T., Chandhoke P.S., Fan J. Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation. Urology. 52:1998;750-755.
27. Strauss A.L., Coe F.L., Parks J.H. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch. Intern. Med. 142:1982;504-507.
28. Pak C.Y., Peters P., Hurt G., Kadesky M., Fine M., Reisman D.et al. Is selective therapy of recurrent nephrolithiasis possible? Am. J. Med. 71:1981;615-622.
29. Bataille P., Fardellone P., Ghazali A., Cayrolle G., Hottelart C., Achard J.M.et al. Pathophysiology and treatment of idiopathic hypercalciuria. Curr. Opin. Rheumatol. 10:1998;373-388.
30. Pak C.Y.C., Resnick M.I. Medical therapy and new approaches to management of urolithiasis. Urol. Clin. North Am. 27:2000;243-253.
31. Ettinger B., Citron J.T., Livermore B., Dolman L.I. Chlortalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J. Urol. 139:1988;679-684.
32. Ettinger B., Pak C.Y., Citron J.T., Thomas C., Adams-Huet B., Vangessel A. Potassium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J. Urol. 158:1997;2069-2073.
33. Baggio B., Plebani M., Gambaro G. Pathogenesis of idiopathic calcium nephrolithiasis: update 1997. Crit. Rev Clin. Lab Sci. 35:1998;153-187.
34. Asplin J.R., Parks J.H., Chen M.S., Lieske J.C., Toback F.G., Pillay S.N.et al. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int. 56:1999;1505-1516.
35. Curhan G.C., Willett W.C., Rimm E.B., Stampfer M.J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl. J. Med. 328:1993;833-838.
36. Borghi L., Schianchi T., Meschi T., Guerra A., Allegri F., Maggiore U.et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N. Engl. J. Med. 346:2002;77-84.
37. Curhan G.C., Willett W.C., Rimm E.B., Spiegelman D., Stampfer M.J. Prospective study of beverage use and the risk of kidney stones. Am. J. Epidemiol. 143:1996;240-247.
38. Curhan G.C., Willett W.C., Rimm E.B., Stampfer M.J. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. J. Urol. 155:1996;1847-1851.
39. Curhan G.C., Willett W.C., Speizer F.E., Stampfer M.J. Intake of vitamins B6 and C and the risk of kidney stones in women. J. Am. Soc. Nephrol. 10:1999;840-845.
40. Curhan G.C., Willett W.C., Rimm E.B., Speizer F.E., Stampfer M.J. Body size and risk of kidney stones. J. Am. Soc. Nephrol. 9:1998;1645-1652.
41. Ljunghall S. Incidence of upper urinary tract stones. Miner Electrolyte Metab. 13:1987;220-227.
42. Soucie J., Coates R., McClellan W., Austin H., Thun M. Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am. J. Epidemiol. 143:1996;487-495.
43. Anderson DA. Historical and geographical differences in the pattern of incidence of urinary stones considered in relation to possible aetiological factors. In: Hodgkinson A, Nordin BEC, editors. Proc. Renal Stone Res. Symp, Leeds, England, April 1968. London: Churchill; 1969. p. 7-31.
44. Robertson W.G., Peacock M., Hodgkinson A. Dietary changes and the incidence of urinary calculi in U.K. between 1958 and 1976. J. Chronic Dis. 32:1979;469-476.
45. Scott R., Cunningham C., McLelland A., Fell G.S., Fitzgerald-Finch O.P., McKellar N. The importance of cadmium as a factor in calcified upper urinary tract stone disease - a prospective 7-year study. Br. J. Urol. 54:1982;584-589.
46. Lieske J.C., Toback F.G. Interaction of urinary crystals with renal epithelial cells in the pathogenesis of nephrolithiasis. Semin. Nephrol. 16:1996;458-473.
47. Nuyts G.D., Van Vlem E., Thys J., De Leersnijder D., D'Haese P.C., Elseviers M.M.et al. New occupational risk factors for chronic renal failure. Lancet. 346:1995;7-11.
48. Robertson WG, Longhorn SE, Whitfield HN, Unwin RJ, Mansell MA, Neild GH. The changing pattern of the age at onset of urinary stone disease in the UK. In: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A, editors. Proc. 8th Eur Symp on Urolith, Parma, Italy, June 1999. Cosenza: Editoriale Bios; 1999. p. 165-8.
49. Lyon T.D., Aughey E., Scott R., Fell G.S. Cadmium concentrations in human kidney in the UK: 1978-1993. J. Environ. Monit. 1:1999;227-231.